The biopharmaceutical industry is positioned for continued recovery, driven by recent FDA approvals and billion-dollar ...

Many investors pay attention to mid-cap stocks because they have established business models and expansive market ...

The resultant sell-off has led to a wipe out of ₹10 lakh crore in the combined market capitalisation of all BSE-listed ...

Discover how to identify undervalued large-cap stocks, find ultra-stable investments, and explore April's top 16 safer ...

Viking's Q1 earnings show no revenue, increased R&D spending, and a substantial cash reserve, positioning it well for future ...

Pharma executives emphasise that without urgent action, Europe may face a decline and an acceleration in the departure of ...

Pittsburgh biotech firms see potential benefits from upcoming tariffs and reshoring efforts, despite uncertainties in NIH ...

Uncertainties surrounding the U.S. pharmaceutical sector and the turbulent development in global stock markets have led to ...

Yarra Capital Management says investor appetite for small caps is returning, spurred by the weak $A and takeover activity. ..

Stock Market Highlights | Indian benchmark equity indices traded lower on Thursday, pressured by heavyweight Reliance ...

Healthcare companies rose after earnings from one Big Pharma company. Merck shares ticked up after the drug giant posted quarterly revenue ahead of Wall Street targets, lifted by growth in sales of ...

Interim Statement on the First Three Months of Financial Year 2025Cohort 7 of the clinical trial of HDP-101 in multiple myeloma safe and well toleratedCohort 8 expected to start soonClinical ...